These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9687402)

  • 61. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).
    Davies TA; Goldschmidt R; Pfleger S; Loeloff M; Bush K; Sahm DF; Evangelista A
    J Antimicrob Chemother; 2003 Aug; 52(2):168-75. PubMed ID: 12837740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
    Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae.
    Perichon B; Tankovic J; Courvalin P
    Antimicrob Agents Chemother; 1997 May; 41(5):1166-7. PubMed ID: 9145891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.
    González I; Georgiou M; Alcaide F; Balas D; Liñares J; de la Campa AG
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2792-8. PubMed ID: 9797205
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
    Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
    J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones.
    Pestova E; Beyer R; Cianciotto NP; Noskin GA; Peterson LR
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2000-4. PubMed ID: 10428926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.
    Giraud E; Brisabois A; Martel JL; Chaslus-Dancla E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2131-7. PubMed ID: 10471553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
    Chen DK; McGeer A; de Azavedo JC; Low DE
    N Engl J Med; 1999 Jul; 341(4):233-9. PubMed ID: 10413735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone.
    Roychoudhury S; Makin K; Twinem T; Leunk R; Hsu MC
    Microb Drug Resist; 2016 Oct; 22(7):578-584. PubMed ID: 27267788
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
    Avrain L; Garvey M; Mesaros N; Glupczynski Y; Mingeot-Leclercq MP; Piddock LJ; Tulkens PM; Vanhoof R; Van Bambeke F
    J Antimicrob Chemother; 2007 Nov; 60(5):965-72. PubMed ID: 17693451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
    Balsalobre L; de la Campa AG
    Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones.
    Janoir C; Varon E; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2001 Mar; 45(3):952-5. PubMed ID: 11181389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.
    Millichap JJ; Pestova E; Siddiqui F; Noskin GA; Peterson LR
    J Clin Microbiol; 2001 Jul; 39(7):2719-21. PubMed ID: 11427605
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
    Chen FJ; Lauderdale TL; Ho M; Lo HJ
    Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.
    Gould KA; Pan XS; Kerns RJ; Fisher LM
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2108-15. PubMed ID: 15155208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program.
    Doern GV; Pfaller MA; Erwin ME; Brueggemann AB; Jones RN
    Diagn Microbiol Infect Dis; 1998 Dec; 32(4):313-6. PubMed ID: 9934549
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-PmrA-mediated multidrug resistance in Streptococcus pneumoniae.
    Pestova E; Millichap JJ; Siddiqui F; Noskin GA; Peterson LR
    J Antimicrob Chemother; 2002 Mar; 49(3):553-6. PubMed ID: 11864959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.